T
Protara Therapeutics, Inc.
TARA · NASDAQ · Healthcare · 223M
Closing price
$2.75
+3.96% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.6×
Enterprise value / EBITDAEV/EBITDA
-1.3×
Free cash flow yieldFCF yield
-47.8%
Return on equityROE
-29.2%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.